GeneDx Holdings (WGS) Total Debt (2020 - 2026)

GeneDx Holdings has disclosed Total Debt across 7 years of filings, most recently posting $96.7 million for Q1 2026.

• In Q1 2026, Total Debt rose 86.76% year-over-year to $96.7 million; the TTM figure through Mar 2026 stood at $96.7 million (up 86.76% YoY), while the FY2025 annual figure was $48.2 million, down 7.2% from the prior year.
• Total Debt grew to $96.7 million in Q1 2026, from $48.2 million in the prior quarter.
• Over the last five years, Total Debt for WGS reached as high as $96.7 million in Q1 2026 and fell as low as $6.1 million in Q3 2023.
• The 5-year median for Total Debt is $51.6 million (2025), against an average of $37.3 million.
• Annual changes were most pronounced in 2023 — Total Debt plunged 53.2% — and 2024, when it soared 759.78%.
• A 5-year view of Total Debt shows it stood at $9.8 million in 2022, then surged by 435.28% to $52.7 million in 2023, then retreated by 1.47% to $51.9 million in 2024, then retreated by 7.2% to $48.2 million in 2025, then soared by 100.79% to $96.7 million in 2026.
• According to Business Quant data, Total Debt over the past three periods registered $96.7 million, $48.2 million, and $51.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.